Mr. Karl Kossen Ph.D. serves as Senior Vice President of Biology at Blade Therapeutics, Inc. Mr. Kossen is a scientific leader with 13 years of experience in pharmaceutical research including drug discovery, drug development and the characterization of disease biology. He has an expert knowledge of fibrotic disease including pathobiology, biomarker strategies and properties of anti-fibrotic drugs. He joined Sirna Therapeutics where he optimized sirna stabilization motifs and supported ocular and respiratory therapeutic programs. He joined InterMune in 2005 where he formed and led core functional teams for anti-fibrotic drug discovery and translational science. Mr. Kossen holds B.S. in Chemistry and Cell and Molecular Biology from the University of Michigan and his Ph.D. in Biochemistry from the University of Colorado. Mr. Karl Kossen Ph.D. serves as Senior Vice President of Biology at Blade Therapeutics, Inc. Mr. Kossen is a scientific leader with 13 years of experience in pharmaceutical research including drug discovery, drug development and the characterization of disease biology. He has an expert knowledge of fibrotic disease including pathobiology, biomarker strategies and properties of anti-fibrotic drugs. He joined Sirna Therapeutics where he optimized sirna stabilization motifs and supported ocular and respiratory therapeutic programs. He joined InterMune in 2005 where he formed and led core functional teams for anti-fibrotic drug discovery and translational science. Mr. Kossen holds B.S. in Chemistry and Cell and Molecular Biology from the University of Michigan and his Ph.D. in Biochemistry from the University of Colorado.

Cellular & Molecular Pathology